The U.S. Supreme Court is about to decide whether a private company can own a piece of our bodies. Right now, a company called Myriad Genetics has a patent on two genes both closely associated with breast and ovarian cancer. The gene patents not only violate the First Amendment and block diagnostic testing and research that could lead to cures, they limit women‘s options regarding their medical care.